Poland· PL-100532151
Nasivin Vicks Aloes i Eukaliptus
A oxymetazoline product containing oxymetazolini hydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Oxymetazoline is registered in 13 of 19 countries.
Countries holding a registration under ATC R01AA05 (oxymetazoline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Oxymetazoline · ATC R01AA05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Oxymetazolini hydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- R01AA05
- ATC class
- Oxymetazoline
- Defined daily dose
- 0.4 mg, N
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991593254
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
58 interactions on record for oxymetazoline.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxymetazoline · interactions on record
58 records
- 7 severe
- 48 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- ErgometrineG02AB03severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxymetazoline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAfrinBayer HealthCare LLC.
- SpainAFRIN AROMA MANZANILLA 0,5 MG/ML SOLUCION PARA PULVERIZACION NASALBayer Hispania S.L.
- SwedenNasin 0,5 mg/ml Nässpray, lösningPerrigo Sverige AB
- NetherlandsAfrin 0,5 mg/ml neusspray, oplossingBayer B.V.
- BelgiumNesivine Eucalyptus 0,5 mg/mlMerck Consumer Healthcare
- FinlandVicksWick Pharma Zweigniederlassung der Procter & Gamble GmbH
- NorwayRhinoxOrifarm Healthcare A/S
- IcelandNezerilPerrigo Sverige AB
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Wick Nasiben Baby Sanft, Wick Nasivin Aloe & Eukalyptus
- Belgium · Nesivine, Nesivine Baby Sine Conservans
- Bulgaria · Vicks Sinex Aloe And Eucalyptus, Африн
- Czechia · Afrin, Afrin S Mentolem
- Germany · Nasivin Erwachsene Und Schulkinder, Nasivin Für Erwachsene Und Schulkinder
- Estonia · Afrin, Afrin Menthol
- Spain · Antirrinum Adultos Nueva Fórmula, Cuvenax
- Finland · Vicks, Vicks Sinex
- France · Chlorhydrate D'oxymétazoline Eg, Pernazene
- United Kingdom (Northern Ireland) · Blocked Nose Relief, Boots Decongestant
- Greece · Ezixin, Ronal
- Croatia · Nazopass, Operil P Za Djecu
- Hungary · Afrin, Afrin Comfort Mentollal
- Ireland · Vicks Sinex Micromist
- Iceland · Nezeril
- Italy · Equimet, Froben Raffreddore
- Lithuania · Afrin, Afrin Menthol
- Luxembourg · Nesivine, Nesivine Baby Sine Conservans
- Latvia · Afrin, Sinex
- Malta · Utabon Adults, Utabon Pediatric
- Netherlands · Afrin, Afrin Met Glycerol
- Norway · Rhinox
- Portugal · Alerjon, Bisolspray Nebulicina Adulto
- Romania · Afrin, Afrin Mentol
- Sweden · Nasin, Nezebi
- Slovenia · Afrin, Nazopass
- Slovakia · Afrin, Afrin S Mentolom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e16609de-078d-4d93-bb48-a98f2bd00741 GET /v1/drugs/e16609de-078d-4d93-bb48-a98f2bd00741?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Aerozol do nosa, roztwór",
"source": "urpl",
"strength": "0,5 mg/ml",
"packaging": "05909991593254 ¦ OTC ¦ 165569\n1 butelka 15 ml",
"substance": "Oxymetazolini hydrochloridum 0.5 mg/ml",
"common_name": "Oxymetazolini hydrochloridum",
"pl_product_id": "100532151",
"pozwolenie_nr": "037/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-01-28"
}See everything about oxymetazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.